Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Members' Business Motion · S5M-12545 · Session 5

Orkambi

Lodged by Maurice Corry Con Lodged 31 May 2018 Debate 12 Jun 2018 29 supporters Cross-party support

The motion

That the Parliament understands that cystic fibrosis affects over 900 people in Scotland, including in the West Scotland parliamentary region, and that, in 2016, half of all people who died from the genetic condition were aged under 31; believes that Orkambi, which is manufactured by Vertex Pharmaceuticals and treats the homozygous delf508 mutation, which around 50% of people in the UK with the condition have, is the second drug to be licensed for use in dealing with cystic fibrosis; notes that the main function of this treatment is to keep a healthy balance of salt and water in the organs, particularly the lungs; believes that, according to 2016 UK Cystic Fibrosis Registry Report, there are 336 people in Scotland who could benefit from having access to this, but that it is not currently available via the NHS, despite, it understands, the Scottish Medicines Consortium noting that it was a beneficial treatment and NICE recognising it as an important treatment; believes that clinical data has shown that the drug is able to slow decline in lung function, which is the main cause of death from the condition, by 42%, and notes the work of all the people and organisations, such as the Cystic Fibrosis Trust, which are campaigning to put pressure on the Scottish Government, the NHS and pharmaceutical companies to ensure that such drugs reach those who need them without delay.

Signatures by party

29 MSPs besides the lodger · 10 from other parties
Con 19Lab 6SNP 2Green 1LD 1

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

29 MSPs

Con 19 Lab 6 SNP 2 Green 1 LD 1

Show all 29 supporters by party

Con 19

Lab 6

SNP 2

Green 1

LD 1

Party shown is each supporter’s party when the motion was published.

In the Official Report

1 contribution mention S5M-12545
  1. 12 Jun 2018
    Orkambi
    Christine Grahame SNP Meeting of the Parliament

    The final item of business is a members’ business debate on motion S5M-12545, in the name of Maurice Corry, on Orkambi. The debate will be concluded without any question being put. Motion debated, That the Parliament understands that cysti…